Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial

This phase 2, open-label, placebo-controlled examines topical itraconazole as a treatment for basal cell carcinoma.

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JAMA Dermatol
Päätekijät: Sohn, Grace K., Kwon, Gina P., Bailey-Healy, Irene, Mirza, Amar, Sarin, Kavita, Oro, Anthony, Tang, Jean Y.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Medical Association 2019
Aiheet:
Research Letter
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6659355/
https://ncbi.nlm.nih.gov/pubmed/31339515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2019.1541
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia